My-Linh joined BlueBay in July 2014 and leads on ESG integration across the firm’s global assets. She was previously at Schroders Investment Management Ltd where she was an ESG Analyst in the Responsible Investment department and involved in conducting ESG analysis and engagement. Prior to this, My-Linh was an Associate Director – SRI Research in the Sustainable and Responsible Investment team at Henderson Global Investors. My-Linh holds a Masters in Leadership for Sustainable Development from Middlesex University/Forum for the Future, a Masters in Environmental Management Systems & Auditing, as well as a degree in Environmental Sciences, both from the University of East Anglia.
She represents BlueBay in interactions with the UN-supported Principles for Responsible Investment (PRI), contributing to ESG in fixed income related publications, as well as actively participating in two working groups, one on ESG Bondholder Engagement, and Advisory Committee on Credit Ratings (as chair). Previous committee and board membership roles have included serving as a non-executive board director of UKSIF, the sustainable investment and finance association (2008-2014); being a member of the Expert Committee for the Access to Medicines Index (2009-2013), participating the SASB healthcare industry working group (2012), as well as serving on GlaxoSmithKline’s EHS Stakeholder Panel (2005-2011).